Gynecology: Breast Pathology

Gynecology and Obstetrics · Clinical Specialties

How it begins

Del desarrollo embriológico de la glándula a la oncología de precisión: un recorrido exhaustivo por la patología benigna, los precursores, el carcinoma invasivo y su manejo clínico contemporáneo.

What it covers

1. Anatomy, Histology and Development of the Mammary Gland
2. · 1.1 Mature Structural Organization
3. · 1.2 Hormone-Dependent Development
4. · 1.3 Vascularization and lymphatic drainage
5. Clinical and Radiological Evaluation of the Breast
6. · 2.1 History and Physical Examination
7. · 2.2 Image Modalities
8. · 2.3 BI-RADS System (Breast Imaging Reporting and Data System)
9. · 2.4 Tissue Diagnostic Procedures
10. Epidemiology and Risk Factors
11. · 2b.1 Non-modifiable risk factors
12. · 2b.2 Modifiable risk factors
13. Benign Breast Pathology
14. · 3.1 Fibrocystic Changes (Fibrocystic Disease)
15. · 3.2 Fibroadenoma
16. · 3.3 Phyllodes Tumor
17. · 3.4 Fat Necrosis
18. · 3.5 Mastitis and Inflammatory Processes
19. · 3.6 Sclerosing Adenosis and Complex Sclerosing Lesion
20. · 3.7 Mastalgia
21. · 3.8 Cysts and telorrhea
22. Proliferative Lesions and Risk of Breast Cancer
23. · 4.1 Usual Ductal Hyperplasia vs. Atypical
24. · 4.2 Lobular Neoplasia (HLA and LCIS)
25. · 4.3 Intraductal Papilloma
26. · 4.4 Clinical implications of risk injuries
27. Carcinoma In Situ: Non-Invasive Precursors
28. · 5.1 Ductal Carcinoma In Situ (DCIS / DCIS)
29. · 5.2 Microinvasion
30. Invasive Breast Carcinoma: Histological Types
31. · 6.1 Histological Grade (Nottingham/Elston-Ellis System, SBR modification)
32. · 6.2 Prognostic and predictive factors
33. Molecular Classification and Immunohistochemistry
34. · 7.1 HER2 (ERBB2): Determination and Meaning
35. · 7.2 Genomic Prognostic Platforms
36. TNM Staging and Prognostic Factors
37. · 8.1 Sentinel Node Biopsy vs. Axillary lymphadenectomy
38. · 8.2 Classic Prognostic Factors
39. · 8.3 Distant metastasis (M) and grouped stages
40. Hereditary Breast Cancer and Predisposition Syndromes
41. · 9.1 Criteria for Referral to Genetic Counseling
42. · 9.2 Management of High-Risk Mutation Carriers
43. · 9.3 The genetic counseling process
44. Principles of Treatment
45. · 10.1 Surgery
46. · 10.2 Radiotherapy
47. · 10.3 Systemic Therapy
48. · 10.4 Neoadjuvant Therapy
49. Special Clinical Situations
50. · 11.1 Pregnancy Associated Breast Cancer (CMAE)
51. · 11.2 Inflammatory Breast Cancer
52. · 11.3 Occult Breast Cancer with Axillary Adenopathy
53. · 11.4 Dense Breast
54. · 11.5 Paget's Disease of the Nipple
55. · 11.6 Recurrence and metastatic disease
56. Breast Pathology in Men
57. · 12.1 Gynecomastia
58. · 12.2 Breast Carcinoma in Males
59. Breast Cancer Screening
60. · 13.1 Mammography as a screening test
61. · 13.2 Screening in high-risk populations
62. Clinical and Diagnostic Imaging
63. · 14.1 Clinical manifestations of breast cancer
64. · 14.2 The triple diagnosis
65. · 14.3 The BI-RADS system
66. · 14.4 Extension study
67. Monitoring and Care for the Survivor
68. · 15.1 Follow-up after treatment
69. · 15.2 Aftermath and quality of life